STOCK TITAN

Babcock & Wilcox: Ameriprise reports 1.1% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Babcock & Wilcox Enterprises, Inc. (BW) is the issuer named in Ameriprise Financial, Inc.’s amended ownership report. Ameriprise reported beneficial ownership of 1,704,893 common shares, or 1.1%, as of September 30, 2026, including shared voting power over 1,656,721 shares and shared dispositive power over 1,704,893 shares. Sole voting and dispositive power were each reported as zero. Ameriprise disclaimed beneficial ownership of the shares reported.

Reported beneficial ownership 1,704,893 shares Ameriprise Financial, Inc.; as of September 30, 2026; Ameriprise disclaimed beneficial ownership of the shares reported.
Percent of class reported 1.1% Babcock & Wilcox Enterprises, Inc. common stock, as of September 30, 2026.
Shared voting power 1,656,721 shares Reported by Ameriprise Financial, Inc.
Shared dispositive power 1,704,893 shares Reported by Ameriprise Financial, Inc.
Sole voting power 0 shares Reported by Ameriprise Financial, Inc.
Sole dispositive power 0 shares Reported by Ameriprise Financial, Inc.
beneficial ownership regulatory
"Ameriprise disclaims beneficial ownership of any shares reported"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared Voting Power regulatory
"Shared Voting Power 1,656,721.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 1,704,893.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BW shares did Ameriprise report?

Ameriprise Financial, Inc. reported beneficial ownership of 1,704,893 BW common shares, or 1.1%, as of September 30, 2026. Ameriprise also disclaimed beneficial ownership of the shares reported.

What voting and dispositive powers did Ameriprise report for BW shares?

Ameriprise reported shared voting power over 1,656,721 shares and shared dispositive power over 1,704,893 shares. It reported zero sole voting power and zero sole dispositive power.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





05614L209

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Ameriprise Financial, Inc.
Signature:/s/ Michael G. Clarke
Name/Title:Michael G. Clarke, Senior Vice President, North America Head of Operations & Investor Services
Date:11/16/2026

Comments accompanying signature: Contact Information Charles Chiesa VP Fund Treasurer Global Operations and Investor Services Telephone: 617-385-9593

Keep reading